tiprankstipranks
Trending News
More News >
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Income Statement

Compare
278 Followers

Revelation Biosciences Income Statement

Last quarter (Q3 2025), Revelation Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Revelation Biosciences's net income was $-1.91M. See Revelation Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 7.98M$ 8.66M$ 10.86M$ 11.95M$ 3.80M
Depreciation and Amortization
$ 27.92K$ 25.05K$ 25.05K$ 16.78K$ 3.80M
EBITDA
$ -7.95M$ -8.63M$ -10.84M$ -11.93M$ 0.00
Operating Income
$ -7.98M$ -8.66M$ -10.86M$ -11.95M$ -3.80M
Other Income/Expenses
$ -7.06M$ 8.54M$ 34.96K$ -36.35K$ 126.00
Pretax Income
$ -15.04M$ -120.25K$ -10.83M$ -11.99M$ -3.80M
Net Income
$ -15.04M$ -120.25K$ -10.83M$ -11.99M$ -3.80M
Per Share Metrics
Basic EPS
$ -87.68$ -8.41$ -9.64K$ -20.40K$ -9.03K
Diluted EPS
$ -87.68$ -8.41$ -9.64K$ -20.40K$ -9.03K
Weighted Average Shares Outstanding
171.51K 14.29K 1.12K--
Weighted Average Shares Outstanding (Diluted)
171.51K 14.29K 1.12K--
Currency in USD

Revelation Biosciences Earnings and Revenue History